ArticleMolecular diversity2015
Synthesis of novel organosilicon compounds possessing highly substituted imidazole core catalyzed by antimony trioxide.
Article in Molecular diversity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 12 citations in OpenAlex.
- Iodoxybenzoic Acid (IBX) in Organic Synthesis: A Septennial Review.Current organic synthesis · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A general synthetic route for the exclusive preparation of tetrasubstituted imidazoles, possessing benzylic methyl groups has been developed using Sb2O3 via solvent-free, one-pot reaction conditions. Detailed results from our investigation on the bromination of the benzylic methyl groups of imidazoles are described. The products generated during this study were utilized as substrates for the synthesis of organosilicon-containing imidazoles. Synthesis of tris(triorganosilyl)methylimidazole derivatives was carried out using organolithium reagents (RSiMe2)3CLi, (R= H, Me, Ph) prepared via metalation of (RSiMe2)3CH with lithiumdiisopropylamide or methyllithium in THF, in excellent yields. (RSiMe2)3CLi, (R= Me, Ph) were treated with formylated imidazole to afford imidazole containing 2,2-bis(organosilyl)ethenyl groups. 2-(4-(2,2-bis(trimethylsilyl)vinyl)phenyl)-1,4,5-triphenyl-1H-imidazole was obtained via Peterson reaction in high yield. However, compound 2-(4-(2,2-bis(dimethyl(phenyl)silyl)vinyl)phenyl)-1,4,5-triphenyl-1H-imidazole was obtained in low yield likely because of the steric hindrance of the (PhSiMe2)3C- group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.